The next board meeting for Compass Therapeutics Inc is on 20 May 2025 for the purpose of H.C. Wainwright 3(rd) Annual BioConnect Investor Conference at NASDAQSee details
Compass Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of 2785.9%, and profit growth estimate of -45.1% for FY26, based on top 9 analyst calls.